Bridging the Lab-to-Market Gap: Professor Reddanna Outlines Blueprint for Pharmaceutical Innovation in Indian Academia

Sri Sai College of Dental Surgery, Vikarabad, has taken a pioneering step in nurturing a research-oriented mindset among dental students right from their first year of professional education. As part of the institution's commitment to academic excellence, various initiatives, collaborations and in-house research support schemes have been introduced to encourage early engagement in scientific inquiry.

- 

The SSCDS Research Committee hosted a significant event titled "Fostering a Culture of Research and Innovation" on 13th May 2025, featuring Professor P. Reddanna, Senior Professor (Rtd.) from the School of Life Sciences, University of Hyderabad, as the keynote speaker.

Professor Reddanna, who also serves as the Executive President of the Federation of Asian Biotech Associations (FABA) and Founder Director of ASPIRE, delivered a compelling presentation on "Innovation and Entrepreneurship Ecosystem in Academic Institutions: University of Hyderabad as a Case Study," with special emphasis on pharmaceutical innovation in India.

Highlighting the critical need for innovative drug development in India, Prof. Reddanna noted that despite India's strong manufacturing capabilities, its share in the global healthcare market remains at only 0.64% ($638 billion out of a $10 trillion global market). "This modest representation stems from the industry's predominant focus on generics and biosimilars—high-volume but low-value products," he explained, urging a strategic shift toward innovation-driven drug development.